Nucleotide raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2026-01-29 and is reviewed periodically as new material appears.
Nicotinamide mononucleotide, abbreviated NMN, is a naturally occurring nucleotide found in the cells of many organisms, including bacteria, plants, and mammals. Its structure consists of a nicotinamide ring attached to a ribose-phosphate group. NMN functions as an intermediate in the NAD+ salvage pathway, a recycling route that regenerates nicotinamide adenine dinucleotide. The enzyme nicotinamide phosphoribosyltransferase produces NMN from nicotinamide and phosphoribosyl pyrophosphate. A second enzyme, NMN adenylyltransferase, then converts NMN into NAD+.
Dietary sources of NMN include small amounts in certain vegetables, fruits, and other foods, although exact values vary by sample and method. Endogenous NMN concentrations are tightly regulated and often low, making measurement in blood or tissues technically demanding. After oral intake, NMN is thought to be rapidly metabolized in the intestine and liver, and intact NMN may not reach all tissues at high levels. Some rodent studies report increases in tissue NAD+ after oral NMN, while human data remain limited and sometimes rely on blood NAD+ metabolites rather than direct tissue measures.
Nicotinamide mononucleotide, commonly abbreviated NMN, is a pyridine nucleotide that consists of a nicotinamide ring, a ribose sugar, and a phosphate group. It is an intermediate in the salvage pathway for nicotinamide adenine dinucleotide, or NAD+, synthesis. In mammalian cells, the enzyme nicotinamide phosphoribosyltransferase produces NMN from nicotinamide and phosphoribosyl pyrophosphate. Nicotinamide mononucleotide adenylyltransferases then convert NMN into NAD+. The core structure and enzymatic route are well established in biochemical literature.
The biologically relevant form of NMN is generally the beta anomer, which is recognized by NMN adenylyltransferases. NMN is polar and water soluble, and it does not readily diffuse across lipid membranes without assistance. Whether intact NMN enters cells through a specific transporter remains an open question; some studies propose solute carrier family members, while other work favors extracellular dephosphorylation to nicotinamide riboside followed by uptake. This transport and compartmentalization debate affects how researchers interpret oral administration studies. The distinction between intracellular synthesis and extracellular delivery is central to current discussion.
| Property | Value | Notes |
|---|---|---|
| Chemical name | Nicotinamide mononucleotide | Nucleotide intermediate in NAD+ salvage pathway |
| Common abbreviation | NMN | Also written as β-NMN |
| Molecular formula | C11H15N2O8P | Uncharged parent form |
| Molar mass | 334.22 g/mol | Calculated from formula |
| CAS Registry Number | 1094-61-7 | For β-nicotinamide mononucleotide |
Nicotinamide mononucleotide, abbreviated NMN, is a naturally occurring nucleotide. Its structure combines a nicotinamide ring, a ribose sugar, and a phosphate group. The compound exists in cells as an intermediate in the production of nicotinamide adenine dinucleotide, a central redox cofactor. NMN is distinct from nicotinamide riboside, another related pyridine nucleotide, although the two compounds can converge in metabolic pathways. Its chemical formula is C11H15N2O8P, and it carries a net negative charge at physiological pH.
In the salvage pathway, NMN is generated from nicotinamide and 5-phosphoribosyl-1-pyrophosphate by the enzyme nicotinamide phosphoribosyltransferase. A second route produces NMN from nicotinamide riboside through phosphorylation by nicotinamide riboside kinases. NMN is then converted to NAD+ by nicotinamide mononucleotide adenylyltransferases, often called NMNAT enzymes. This stepwise route allows cells to recycle nicotinamide and maintain NAD+ levels under changing metabolic conditions. The relative contribution of each route varies by tissue, species, and physiological state, and it remains an active area of research.
Nicotinamide mononucleotide, abbreviated NMN, is a naturally occurring nucleotide. Its structure combines a nicotinamide base with a ribose sugar and a phosphate group. Within cells, NMN sits on the biosynthetic route that recycles nicotinamide back into nicotinamide adenine dinucleotide, or NAD+. Because NAD+ participates in redox reactions and signaling, enzymes that produce and consume it influence many metabolic processes. The compound is therefore best described as an intermediate rather than a final signaling molecule.
In the canonical salvage pathway, nicotinamide phosphoribosyltransferase, known as NAMPT, transfers a phosphoribosyl group to nicotinamide and releases NMN. A second enzyme, NMN adenylyltransferase, then attaches an adenylyl group to NMN to form NAD+. Alternative routes exist, including a pathway that uses nicotinamide riboside and its phosphorylated forms. The relative contribution of extracellular NMN to intracellular NAD+ pools remains an area of active investigation, and the roles of specific transporters and enzymes are not completely defined.
In late October, Gaza's premature babies faced a critical situation as Medical Aid for Palestinians and UNICEF warned that 130 infants were at risk of death due to a hospital fuel shortage caused by Israel's siege. The lack of fuel led to power outages, endangering premature babies in neonatal intensive care units (NICUs). Despite assurances from the IDF to assist in evacuations, the Gaza Health Ministry reported a lack of evacuation mechanisms, resulting in the deaths of several infants. The situation escalated in mid-November when Israel launched a raid on al-Shifa Hospital. Evacuations eventually occurred, facilitated by the Palestinian Red Crescent, World Health Organization, and UNOCHA, with 31 premature babies moved to southern Gaza, with most then to Egypt. Not all infants were accompanied by their parents, and two died at al-Shifa before the evacuation. The distress extended to Al-Nasr Children's Hospital, bombed by the IDF in early November, where medical workers had to leave babies in incubators during evacuation. Video footage later revealed the aftermath, with five premature babies found dead in their incubators. The IDF initially denied responsibility, though an Israel official was heard providing assurances to evacuate the hospital in a released audio. In mid-December, a military siege on Kamal Adwan Hospital worsened the situation, as IDF soldiers reportedly prevented staff from supporting 12 babies in intensive care.
==== Juvenile breast hypertrophy ==== In 1993, the Japanese journal Surgery Today reported on the case of a 12-year-old girl. Only 152 centimetres (60 in) tall and weighing 43 kilograms (95 lb), her breasts began to develop at age 11 before the onset of menstruation. Over the next eight months, both breasts grew abnormally large, and physicians treating her found that her physiological development was normal except for her breasts. The weight produced by their symmetrical and massive enlargement resulted in marked curvature of the spine. Lab tests of her blood for hormones and biochemical substances showed normal values, though tests revealed that it might have been caused by hypersensitivity to estrogen. She underwent a bilateral reduction mammoplasty. Surgeons removed 2 kilograms (4.4 lb) of tissue from her right breast and 1.9 kilograms (4.2 lb) from her left breast. She was administered tamoxifen afterward to suppress breast regrowth. A more severe case of juvenile breast hypertrophy of an 11-year-old girl was reported in 2008. The breasts had begun to grow rapidly at puberty and had reached the point of causing physical and psychological impairment and possible respiratory compromise after ten months. The skin was intact without any ulcerations. Blood chemistry and endocrine investigation was normal. A bilateral reduction mammaplasty with free nipple grafts was performed. 6 kg (13 lb) of the right breast and 6.5 kg (14 lb) of the left breast were removed, resulting in a removal of 12.5 kg (28 lb) of tissue in all (24% of the total body weight).
There are varied reasons for e-cigarette use. Most users are trying to quit smoking, but some use is recreational or as an attempt to get around smoke-free laws. Many people vape to relax, and some because vaping is safer than smoking. The wide choice of flavors and lower price compared to cigarettes are also important factors. Other motivations include reduced odor and fewer stains. E-cigarettes also appeal to technophiles who enjoy customizing their devices.
Sources: en.wikipedia.org
=== Pharmacodynamics === Several in vitro and in vivo studies have demonstrated that dihydroergocriptine is an effective anti-Parkinson drug, most likely exerting its effects as a potent agonist of D2 receptors. The Kd of DHEC is found to be around 5-8 nM at D2 receptors. Less certain is the contribution of its partial D1 receptor and D3 receptor agonist activity. DHEC has a lower affinity for D1 and D3 receptors (Kd is around 30 nM for both) than for D2 receptors. It is widely believed that dopamine receptor agonists demonstrate their antiparkinsonian effects by stimulating D2 receptors primarily, but other dopamine receptors, such as D1 and D3 may be involved. Remarkably, DHEC is said to not significantly interact with serotonergic and adrenergic receptors.
Although very common, nipple pain and nipple trauma (cracking, open sores) should not be normalized, as these are often signs of a shallow latch or other underlying problem that can be evaluated and fixed. In addition to shallow latch, other causes of nipple pain include, but are not limited to, skin infection or inflammation, blood vessel spasm or the equivalent of Raynaud Syndrome in the breast, mastitis, plugged ducts, and nipple blebs. Pain caused by a problem deep in the breast may also present with nipple pain due to the paths of nerves in the breast. In addition to the serious nature of many of these causes, nipple pain is a common reason for a mother stopping breastfeeding, so mothers experiencing nipple pain must be evaluated.
== Adverse effects == The most significant adverse effects associated with topiramate treatment are predominantly central nervous system (CNS) related. A notable proportion of patients, ranging from 11% to 28%, discontinue topiramate therapy due to adverse effects. People taking topiramate should be aware of the following risks:
Sources: en.wikipedia.org
Mary Brown's operated mainly in Newfoundland (about 20 locations with 2 locations in Halifax and 1 in Ontario) until the late 1970s, when it began expanding in Ontario, Alberta and Nova Scotia. In 2010, there were 38 locations in Newfoundland and Labrador, 30 locations in Ontario, 12 in Alberta and 3 in Nova Scotia, for an approximate total of 83. As of 2017, Mary Brown's has expanded into the United States, specifically in Florida. Drive-through and delivery services are available at some locations. The restaurant chain, started by Newfoundlanders Pat Tarrant and Cyril Fleming in 1969, was named after Mary Brown, the wife of a fried chicken recipe creator. The headquarters are in Markham, Ontario.
Belize became the first country in the world to completely ban bottom trawling in December 2010. In December 2015, Belize banned offshore oil drilling within 1 km (0.6 mi) of the Barrier Reef and all of its seven World Heritage Sites. In 2017, the Government and people of Belize made marine conservation history implementing an indefinite moratorium on offshore oil activities everywhere Belize exercises maritime jurisdiction. This move was further bolstered when the Government enacted law which requires a referendum if there is any move to lift the moratorium. Despite these protective measures, the reef remains under threat from oceanic pollution as well as uncontrolled tourism, shipping, and fishing. Other threats include hurricanes, climate change and the resulting increase in ocean temperatures, which causes coral bleaching. It is claimed by scientists that over 40% of Belize's coral reef has been damaged since 1998.
The Komodo dragon is classified by the IUCN as Endangered and is listed on the IUCN Red List. The species' sensitivity to natural and human-made threats has long been recognized by conservationists, zoological societies, and the Indonesian government. Komodo National Park was founded in 1980 to protect Komodo dragon populations on islands including Komodo, Rinca, and Padar. Later, the Wae Wuul and Wolo Tado Reserves were opened on Flores to aid Komodo dragon conservation. Volcanic activity, earthquakes, loss of habitat, fire, tourism, loss of prey due to poaching, and illegal poaching of the dragons themselves have all contributed to the vulnerable status of the Komodo dragon. A major future threat to the species is climate change via both aridification and sea level rise, which can affect the low-lying habitats and valleys that the Komodo dragon depends on, as Komodo dragons do not range into the higher-altitude regions of the islands they inhabit. Based on projections, climate change will lead to a decline in suitable habitat of 8.4%, 30.2%, or 71% by 2050 depending on the climate change scenario. Without effective conservation actions, populations on Flores are extirpated in all scenarios, while in the more extreme scenarios, only the populations on Komodo and Rinca persist in highly reduced numbers. Rapid climate change mitigation is crucial for conserving the species in the wild. Other scientists have disputed the conclusions about the effects of climate change on Komodo dragon populations.
Sources: en.wikipedia.org
NMN is nicotinamide mononucleotide, a nucleotide intermediate in the NAD+ salvage pathway. Cells use it to help regenerate NAD+, a coenzyme involved in energy metabolism and cellular signaling. It is present naturally in many organisms and is also produced synthetically for research and consumer products.
NMN is the immediate precursor to NAD+ in the salvage pathway. The enzyme NMN adenylyltransferase adds an adenylate group to NMN to form NAD+. Because NAD+ levels decline with age in some tissues, researchers study whether raising NMN availability can influence NAD+ metabolism.
No. Human evidence is limited, and no regulatory agency has approved NMN for treating or preventing aging. Some trials measure NAD+ metabolites or metabolic markers, but their results do not establish a clinical benefit. Larger, longer studies with standardized endpoints are needed.
NMN stands for nicotinamide mononucleotide. It is a naturally occurring nucleotide intermediate in NAD+ biosynthesis.